Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Schrauder MG"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-9 z 9
    Tytuł:
    Development and proof-of-concept of a multicenter, patient-centered cancer registry for breast cancer patients with metastatic disease-the "Breast cancer care for patients with metastatic disease" (BRE-4-MED) registry.
    Autorzy:
    Stangl S; 1Institute of Clinical Epidemiology and Biometry (ICE-B), University of Würzburg, Würzburg, Germany.; 2Department of Gynecology and Obstetrics, University Hospital Würzburg, Würzburg, Germany.
    Haas K; 1Institute of Clinical Epidemiology and Biometry (ICE-B), University of Würzburg, Würzburg, Germany.
    Eichner FA; 1Institute of Clinical Epidemiology and Biometry (ICE-B), University of Würzburg, Würzburg, Germany.
    Grau A; 1Institute of Clinical Epidemiology and Biometry (ICE-B), University of Würzburg, Würzburg, Germany.
    Selig U; 1Institute of Clinical Epidemiology and Biometry (ICE-B), University of Würzburg, Würzburg, Germany.
    Ludwig T; 1Institute of Clinical Epidemiology and Biometry (ICE-B), University of Würzburg, Würzburg, Germany.
    Fehm T; 3Department of Obstetrics and Gynecology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
    Stüber T; 2Department of Gynecology and Obstetrics, University Hospital Würzburg, Würzburg, Germany.
    Rashid A; Zentrum für Telemedizin Bad Kissingen (ZTM), Bad Kissingen, Germany.
    Kerscher A; 5Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany.; Clinical Cancer Registry Lower Franconia, Würzburg, Germany.
    Bargou R; 5Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany.
    Hermann S; 7Epidemiological Cancer Registry Baden-Württemberg, German Cancer Research Center, Heidelberg, Germany.
    Arndt V; 7Epidemiological Cancer Registry Baden-Württemberg, German Cancer Research Center, Heidelberg, Germany.
    Meyer M; 8Centre of Early Cancer Detection and Cancer Registration, Bavarian Health and Food Safety Authority, Nürnberg, Germany.
    Wildner M; 9Bavarian Health and Food Safety Authority, Munich, Germany.
    Faller H; 5Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany.; 10Department of Medical Psychology and Psychotherapy, Medical Sociology and Rehabilitation Sciences, University of Würzburg, Würzburg, Germany.
    Schrauder MG; Clinic of Gynecology and Obstetrics, Hospital Aschaffenburg-Alzenau, Aschaffenburg, Germany.
    Weigel M; Clinic for Gynecology and Obstetrics, Hospital Leopoldina Schweinfurt, Schweinfurt, Germany.
    Schlembach U; Clinic of Gynecology, Caritas Hospital Bad Mergentheim, Bad Mergentheim, Germany.
    Heuschmann PU; 1Institute of Clinical Epidemiology and Biometry (ICE-B), University of Würzburg, Würzburg, Germany.; 14Center for Clinical Studies, University Hospital Würzburg, Würzburg, Germany.; Comprehensive Heart Failure Centre, Würzburg, Germany.
    Wöckel A; 2Department of Gynecology and Obstetrics, University Hospital Würzburg, Würzburg, Germany.
    Pokaż więcej
    Źródło:
    Pilot and feasibility studies [Pilot Feasibility Stud] 2020 Feb 04; Vol. 6, pp. 11. Date of Electronic Publication: 2020 Feb 04 (Print Publication: 2020).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer.
    Autorzy:
    Kahraman M; Clinical Bioinformatics, Saarland University, Homburg, Germany.; Hummingbird Diagnostics GmbH, Heidelberg, Germany.
    Röske A; Hummingbird Diagnostics GmbH, Heidelberg, Germany.
    Laufer T; Hummingbird Diagnostics GmbH, Heidelberg, Germany.
    Fehlmann T; Clinical Bioinformatics, Saarland University, Homburg, Germany.
    Backes C; Clinical Bioinformatics, Saarland University, Homburg, Germany.
    Kern F; Clinical Bioinformatics, Saarland University, Homburg, Germany.
    Kohlhaas J; Hummingbird Diagnostics GmbH, Heidelberg, Germany.
    Schrörs H; Hummingbird Diagnostics GmbH, Heidelberg, Germany.
    Saiz A; Hummingbird Diagnostics GmbH, Heidelberg, Germany.
    Zabler C; Hummingbird Diagnostics GmbH, Heidelberg, Germany.
    Ludwig N; Department of Human Genetics, Saarland University, Homburg, Germany.
    Fasching PA; Friedrich-Alexander University Erlangen-Nürnberg (FAU), Department of Obstetrics and Gynecology, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
    Strick R; Friedrich-Alexander University Erlangen-Nürnberg (FAU), Department of Obstetrics and Gynecology, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
    Rübner M; Friedrich-Alexander University Erlangen-Nürnberg (FAU), Department of Obstetrics and Gynecology, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
    Beckmann MW; Friedrich-Alexander University Erlangen-Nürnberg (FAU), Department of Obstetrics and Gynecology, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
    Meese E; Department of Human Genetics, Saarland University, Homburg, Germany.
    Keller A; Clinical Bioinformatics, Saarland University, Homburg, Germany. .
    Schrauder MG; Friedrich-Alexander University Erlangen-Nürnberg (FAU), Department of Obstetrics and Gynecology, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2018 Aug 02; Vol. 8 (1), pp. 11584. Date of Electronic Publication: 2018 Aug 02.
    Typ publikacji:
    Clinical Trial; Journal Article
    MeSH Terms:
    MicroRNAs*/genetics
    MicroRNAs*/metabolism
    Neoadjuvant Therapy*
    Triple Negative Breast Neoplasms*/blood
    Triple Negative Breast Neoplasms*/diagnosis
    Triple Negative Breast Neoplasms*/pathology
    Triple Negative Breast Neoplasms*/therapy
    Biomarkers, Tumor/*blood
    RNA, Neoplasm/*blood
    Biopsy, Needle ; Early Detection of Cancer ; Female ; Follow-Up Studies ; Humans ; Metabolomics ; Middle Aged ; Oligonucleotide Array Sequence Analysis ; Prospective Studies ; Real-Time Polymerase Chain Reaction
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Knowledge and attitudes regarding medical research studies among patients with breast cancer and gynecological diseases.
    Autorzy:
    Lux MP; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University, Universitätsstrasse 21-23, 91054, Erlangen, Germany. .
    Hildebrandt T; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University, Universitätsstrasse 21-23, 91054, Erlangen, Germany. .
    Knetzger SM; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University, Universitätsstrasse 21-23, 91054, Erlangen, Germany. .
    Schrauder MG; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University, Universitätsstrasse 21-23, 91054, Erlangen, Germany. michael.schrauder@uk-erlangen.de.
    Jud SM; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University, Universitätsstrasse 21-23, 91054, Erlangen, Germany. .
    Hein A; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University, Universitätsstrasse 21-23, 91054, Erlangen, Germany. .
    Rauh C; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University, Universitätsstrasse 21-23, 91054, Erlangen, Germany. .
    Fasching PA; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University, Universitätsstrasse 21-23, 91054, Erlangen, Germany. .
    Beckmann MW; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University, Universitätsstrasse 21-23, 91054, Erlangen, Germany. .
    Thiel FC; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University, Universitätsstrasse 21-23, 91054, Erlangen, Germany. .
    Pokaż więcej
    Źródło:
    BMC cancer [BMC Cancer] 2015 Aug 14; Vol. 15, pp. 587. Date of Electronic Publication: 2015 Aug 14.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Health Knowledge, Attitudes, Practice*
    Breast Neoplasms/*epidemiology
    Breast Neoplasms/*psychology
    Clinical Studies as Topic/*psychology
    Genital Diseases, Female/*epidemiology
    Genital Diseases, Female/*psychology
    Adolescent ; Adult ; Aged ; Aged, 80 and over ; Biomedical Research ; Cross-Sectional Studies ; Female ; Humans ; Middle Aged ; Surveys and Questionnaires ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection.
    Autorzy:
    Garczyk S; Molecular Oncology Group, Institute of Pathology, Medical Faculty of the RWTH Aachen University, Aachen, Germany.
    von Stillfried S; Molecular Oncology Group, Institute of Pathology, Medical Faculty of the RWTH Aachen University, Aachen, Germany.
    Antonopoulos W; Molecular Oncology Group, Institute of Pathology, Medical Faculty of the RWTH Aachen University, Aachen, Germany.
    Hartmann A; Institute of Pathology, University Hospital Erlangen, Erlangen, Germany.
    Schrauder MG; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany.
    Fasching PA; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany.
    Anzeneder T; Patients' Tumor Bank of Hope (PATH) Foundation, München, Germany.
    Tannapfel A; Institute of Pathology, Ruhr-University Bochum, Bochum, Germany, on behalf of the PATH Biobank group.
    Ergönenc Y; Department for Senology, St Anna Hospital, Herne, Germany, on behalf of the PATH Biobank group.
    Knüchel R; Molecular Oncology Group, Institute of Pathology, Medical Faculty of the RWTH Aachen University, Aachen, Germany.
    Rose M; Molecular Oncology Group, Institute of Pathology, Medical Faculty of the RWTH Aachen University, Aachen, Germany.
    Dahl E; Molecular Oncology Group, Institute of Pathology, Medical Faculty of the RWTH Aachen University, Aachen, Germany.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2015 Apr 15; Vol. 10 (4), pp. e0122106. Date of Electronic Publication: 2015 Apr 15 (Print Publication: 2015).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Early Diagnosis*
    Biomarkers, Tumor/*metabolism
    Breast Neoplasms/*diagnosis
    Carrier Proteins/*metabolism
    Neoplasm Proteins/*metabolism
    Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/blood ; Biomarkers, Tumor/genetics ; Blotting, Western ; Breast Neoplasms/genetics ; Breast Neoplasms/metabolism ; Carrier Proteins/blood ; Carrier Proteins/genetics ; Cohort Studies ; Enzyme-Linked Immunosorbent Assay ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Immunohistochemistry/statistics & numerical data ; Kaplan-Meier Estimate ; Middle Aged ; Mucoproteins ; Multivariate Analysis ; Neoplasm Proteins/blood ; Neoplasm Proteins/genetics ; Oncogene Proteins ; Prognosis ; Proportional Hazards Models ; Proteins/metabolism ; ROC Curve ; Reverse Transcriptase Polymerase Chain Reaction
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    miRNAs can be generally associated with human pathologies as exemplified for miR-144.
    Autorzy:
    Keller A; Chair for Clinical Bioinformatics, Saarland University, Saarbrücken, Germany. .
    Leidinger P; Institute of Human Genetics, Saarland University, Homburg, Germany. .
    Vogel B; Department of Internal Medicine III, University of Heidelberg, Heidelberg, Germany. .
    Backes C; Chair for Clinical Bioinformatics, Saarland University, Saarbrücken, Germany. .
    ElSharawy A; Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel, Kiel, Germany. .
    Galata V; Chair for Clinical Bioinformatics, Saarland University, Saarbrücken, Germany. .
    Mueller SC; Chair for Clinical Bioinformatics, Saarland University, Saarbrücken, Germany. .
    Marquart S; Department of Internal Medicine III, University of Heidelberg, Heidelberg, Germany. .
    Schrauder MG; Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany. michael.schrauder@uk-erlangen.de.
    Strick R; Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany. .
    Bauer A; German Cancer Research Center, Heidelberg, Germany. .
    Wischhusen J; University Hospital Würzburg, Würzburg, Germany. wischhusen_.
    Beier M; Comprehensive Biomarker Center, Heidelberg, Germany. .
    Kohlhaas J; Comprehensive Biomarker Center, Heidelberg, Germany. .
    Katus HA; Department of Internal Medicine III, University of Heidelberg, Heidelberg, Germany. .; German Center for Cardiovascular Research - DZHK, Germany, Heidelberg. .
    Hoheisel J; German Cancer Research Center, Heidelberg, Germany. .
    Franke A; Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel, Kiel, Germany. .
    Meder B; Department of Internal Medicine III, University of Heidelberg, Heidelberg, Germany. .; German Center for Cardiovascular Research - DZHK, Germany, Heidelberg. .
    Meese E; Institute of Human Genetics, Saarland University, Homburg, Germany. .
    Pokaż więcej
    Źródło:
    BMC medicine [BMC Med] 2014 Dec 03; Vol. 12, pp. 224. Date of Electronic Publication: 2014 Dec 03.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't; Validation Study
    MeSH Terms:
    Biomarkers, Tumor/*genetics
    Breast Neoplasms/*genetics
    MicroRNAs/*genetics
    Breast Neoplasms/pathology ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Male ; Middle Aged ; Neoplasms/genetics ; Neoplasms/pathology ; Phenotype ; Prognosis
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    MicroRNA related polymorphisms and breast cancer risk.
    Autorzy:
    Khan S; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
    Greco D; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; Finnish Institute of Occupational Health, Helsinki, Finland.
    Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
    Milne RL; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
    Muranen TA; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
    Heikkinen T; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
    Aaltonen K; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; Department of Clinical Genetics, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; Department of Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
    Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
    Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
    Liu J; Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore.
    Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
    Irwanto A; Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore.
    Humphreys K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
    Li J; Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore.
    Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
    Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
    Hein R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany.
    Rudolph A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
    Seibold P; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
    Flesch-Janys D; Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany.
    Fletcher O; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.
    Peto J; Department of Non-Communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, United Kingdom.
    dos Santos Silva I; Department of Non-Communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, United Kingdom.
    Johnson N; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.
    Gibson L; Department of Non-Communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, United Kingdom.
    Aitken Z; Department of Non-Communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, United Kingdom.
    Hopper JL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
    Tsimiklis H; Department of Pathology, The University of Melbourne, Melbourne, Australia.
    Bui M; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
    Makalic E; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
    Schmidt DF; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
    Southey MC; Department of Pathology, The University of Melbourne, Melbourne, Australia.
    Apicella C; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
    Stone J; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
    Waisfisz Q; Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands.
    Meijers-Heijboer H; Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands.
    Adank MA; Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands.
    van der Luijt RB; Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
    Meindl A; Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany.
    Schmutzler RK; Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, University Hospital of Cologne, Cologne, Germany; Center of Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
    Müller-Myhsok B; Max Planck Institute of Psychiatry, Munich, Germany.
    Lichtner P; Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
    Turnbull C; Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom.
    Rahman N; Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom.
    Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America.
    Hunter DJ; Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America.
    Cox A; CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield, United Kingdom.
    Cross SS; Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, United Kingdom.
    Reed MW; CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield, United Kingdom.
    Schmidt MK; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
    Broeks A; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
    Van't Veer LJ; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
    Hogervorst FB; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
    Fasching PA; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Cancer Erlangen-EMN, Erlangen, Germany; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California Los Angeles, California, United States of America.
    Schrauder MG; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Cancer Erlangen-EMN, Erlangen, Germany.
    Ekici AB; Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
    Beckmann MW; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Cancer Erlangen-EMN, Erlangen, Germany.
    Bojesen SE; Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
    Nordestgaard BG; Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
    Nielsen SF; Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
    Flyger H; Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
    Benitez J; Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain.
    Zamora PM; Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, Spain.
    Perez JI; Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain.
    Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
    Henderson BE; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
    Schumacher F; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
    Le Marchand L; Epidemiology Program, Cancer Research Center, University of Hawaii, Honolulu, Hawaii, United States of America.
    Pharoah PD; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
    Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
    Shah M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
    Luben R; Clinical Gerontology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
    Brown J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
    Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America.
    Wang X; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America.
    Vachon C; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
    Olson JE; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
    Lambrechts D; Vesalius Research Center (VRC), VIB, Leuven, Belgium; Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium.
    Moisse M; Vesalius Research Center (VRC), VIB, Leuven, Belgium; Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium.
    Paridaens R; Oncology Department, University Hospital Gasthuisberg, Leuven, Belgium.
    Christiaens MR; Oncology Department, University Hospital Gasthuisberg, Leuven, Belgium.
    Guénel P; Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France; University Paris-Sud, UMRS 1018, Villejuif, France.
    Truong T; Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France; University Paris-Sud, UMRS 1018, Villejuif, France.
    Laurent-Puig P; Université Paris Sorbonne Cité, UMR-S775 Inserm, Paris, France.
    Mulot C; Université Paris Sorbonne Cité, UMR-S775 Inserm, Paris, France.
    Marme F; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
    Burwinkel B; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
    Schneeweiss A; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
    Sohn C; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
    Sawyer EJ; Research Oncology, Division of Cancer Studies, King's College London, Guy's Hospital, London, United Kingdom.
    Tomlinson I; Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
    Kerin MJ; Clinical Science Institute, University Hospital Galway, Galway, Ireland.
    Miller N; Clinical Science Institute, University Hospital Galway, Galway, Ireland.
    Andrulis IL; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
    Knight JA; Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
    Tchatchou S; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
    Mulligan AM; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine, and the Keenan Research Centre of the Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada.
    Dörk T; Department of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany.
    Bogdanova NV; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
    Antonenkova NN; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
    Anton-Culver H; Department of Epidemiology, University of California Irvine, Irvine, California, United States of America.
    Darabi H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
    Eriksson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
    Garcia-Closas M; Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom.
    Figueroa J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America.
    Lissowska J; Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
    Brinton L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America.
    Devilee P; Department of Human Genetics & Department of Pathology, Leiden University Medical Center, Leiden, Netherlands.
    Tollenaar RA; Department of Surgical Oncology, Leiden University Medical Center, Leiden, Netherlands.
    Seynaeve C; Family Cancer Clinic, Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, Netherlands.
    van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands.
    Kristensen VN; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Clinical Molecular Biology (EpiGen), University of Oslo, Oslo, Norway; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.
    Slager S; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
    Toland AE; Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America.
    Ambrosone CB; Roswell Park Cancer Institute, Buffalo, New York, United States of America.
    Yannoukakos D; Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific Research 'Demokritos', Aghia Paraskevi Attikis, Athens, Greece.
    Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
    Margolin S; Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden.
    Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
    Peterlongo P; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy.
    Barile M; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), Milan, Italy.
    Mariani P; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy; Cogentech Cancer Genetic Test Laboratory, Milan, Italy.
    Hooning MJ; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands.
    Martens JW; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands.
    Collée JM; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
    Jager A; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands.
    Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
    Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
    Jaworska-Bieniek K; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; Postgraduate School of Molecular Medicine, Warsaw Medical University, Warsaw, Poland.
    Durda K; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
    Giles GG; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
    McLean C; Anatomical Pathology, The Alfred Hospital, Melbourne, Australia.
    Brauch H; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tübingen, Tübingen, Germany.
    Brüning T; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-University Bochum (IPA), Bochum, Germany.
    Ko YD; Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany.
    Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.
    Dieffenbach AK; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.
    Arndt V; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
    Stegmaier C; Saarland Cancer Registry, Saarbrücken, Germany.
    Swerdlow A; Division of Genetics and Epidemiology and Division of Breast Cancer Research, The Institute of Cancer Research, Sutton, Surrey, United Kingdom.
    Ashworth A; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.
    Orr N; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.
    Jones M; Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom.
    Simard J; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec, Canada.
    Goldberg MS; Department of Medicine, McGill University, Montreal, Canada; Division of Clinical Epidemiology, McGill University Health Centre, Royal Victoria Hospital, Montreal, Quebec, Canada.
    Labrèche F; Départements de Santé Environnementale et Santé au Travail et de Médecine Sociale et Préventive, Université de Montréal, Montreal, Quebec, Canada.
    Dumont M; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec, Canada.
    Winqvist R; Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, NordLab Oulu/Oulu University Hospital, Oulu, Finland.
    Pylkäs K; Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, NordLab Oulu/Oulu University Hospital, Oulu, Finland.
    Jukkola-Vuorinen A; Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland.
    Grip M; Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland.
    Kataja V; School of Medicine, Institute of Clinical Medicine, Oncology, University of Eastern Finland, Kuopio, Finland; Cancer Center, Kuopio University Hospital, Kuopio, Finland.
    Kosma VM; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland; Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
    Hartikainen JM; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland; Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
    Mannermaa A; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland; Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
    Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
    Chenevix-Trench G; Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
    Blomqvist C; Department of Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
    Aittomäki K; Department of Clinical Genetics, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
    Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
    Nevanlinna H; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
    Pokaż więcej
    Corporate Authors:
    kConFab Investigators
    Australian Ovarian Cancer Study Group
    GENICA Network
    Źródło:
    PloS one [PLoS One] 2014 Nov 12; Vol. 9 (11), pp. e109973. Date of Electronic Publication: 2014 Nov 12 (Print Publication: 2014).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
    MeSH Terms:
    Polymorphism, Single Nucleotide*
    Breast Neoplasms/*diagnosis
    Breast Neoplasms/*genetics
    MicroRNAs/*genetics
    3' Untranslated Regions ; Binding Sites ; Case-Control Studies ; Chromosome Mapping ; Computational Biology ; Female ; Genome-Wide Association Study ; Genotype ; Humans ; Receptors, Estrogen/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Polymorphisms in the RANK/RANKL genes and their effect on bone specific prognosis in breast cancer patients.
    Autorzy:
    Hein A; Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
    Bayer CM; Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
    Schrauder MG; Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
    Häberle L; Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
    Heusinger K; Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
    Strick R; Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
    Ruebner M; Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
    Lux MP; Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
    Renner SP; Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
    Schulz-Wendtland R; Institute of Diagnostic Radiology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
    Ekici AB; Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
    Hartmann A; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
    Beckmann MW; Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
    Fasching PA; Department of Gynecology and Obstetrics, University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
    Pokaż więcej
    Źródło:
    BioMed research international [Biomed Res Int] 2014; Vol. 2014, pp. 842452. Date of Electronic Publication: 2014 Mar 05.
    Typ publikacji:
    Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Bone Neoplasms*/genetics
    Bone Neoplasms*/mortality
    Bone Neoplasms*/pathology
    Bone Neoplasms*/secondary
    Breast Neoplasms*/genetics
    Breast Neoplasms*/mortality
    Breast Neoplasms*/pathology
    Polymorphism, Single Nucleotide*
    RANK Ligand/*genetics
    Receptor Activator of Nuclear Factor-kappa B/*genetics
    Aged ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Middle Aged ; Neoplasm Metastasis ; Retrospective Studies ; Survival Rate
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Genome-wide association studies identify four ER negative-specific breast cancer risk loci.
    Autorzy:
    Garcia-Closas M; 1] Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, UK. [2] Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. [3].
    Couch FJ
    Lindstrom S
    Michailidou K
    Schmidt MK
    Brook MN
    Orr N
    Rhie SK
    Riboli E
    Feigelson HS
    Le Marchand L
    Buring JE
    Eccles D
    Miron P
    Fasching PA
    Brauch H
    Chang-Claude J
    Carpenter J
    Godwin AK
    Nevanlinna H
    Giles GG
    Cox A
    Hopper JL
    Bolla MK
    Wang Q
    Dennis J
    Dicks E
    Howat WJ
    Schoof N
    Bojesen SE
    Lambrechts D
    Broeks A
    Andrulis IL
    Guénel P
    Burwinkel B
    Sawyer EJ
    Hollestelle A
    Fletcher O
    Winqvist R
    Brenner H
    Mannermaa A
    Hamann U
    Meindl A
    Lindblom A
    Zheng W
    Devillee P
    Goldberg MS
    Lubinski J
    Kristensen V
    Swerdlow A
    Anton-Culver H
    Dörk T
    Muir K
    Matsuo K
    Wu AH
    Radice P
    Teo SH
    Shu XO
    Blot W
    Kang D
    Hartman M
    Sangrajrang S
    Shen CY
    Southey MC
    Park DJ
    Hammet F
    Stone J
    Veer LJ
    Rutgers EJ
    Lophatananon A
    Stewart-Brown S
    Siriwanarangsan P
    Peto J
    Schrauder MG
    Ekici AB
    Beckmann MW
    Dos Santos Silva I
    Johnson N
    Warren H
    Tomlinson I
    Kerin MJ
    Miller N
    Marme F
    Schneeweiss A
    Sohn C
    Truong T
    Laurent-Puig P
    Kerbrat P
    Nordestgaard BG
    Nielsen SF
    Flyger H
    Milne RL
    Perez JI
    Menéndez P
    Müller H
    Arndt V
    Stegmaier C
    Lichtner P
    Lochmann M
    Justenhoven C
    Ko YD
    Muranen TA
    Aittomäki K
    Blomqvist C
    Greco D
    Heikkinen T
    Ito H
    Iwata H
    Yatabe Y
    Antonenkova NN
    Margolin S
    Kataja V
    Kosma VM
    Hartikainen JM
    Balleine R
    Tseng CC
    Berg DV
    Stram DO
    Neven P
    Dieudonné AS
    Leunen K
    Rudolph A
    Nickels S
    Flesch-Janys D
    Peterlongo P
    Peissel B
    Bernard L
    Olson JE
    Wang X
    Stevens K
    Severi G
    Baglietto L
    McLean C
    Coetzee GA
    Feng Y
    Henderson BE
    Schumacher F
    Bogdanova NV
    Labrèche F
    Dumont M
    Yip CH
    Taib NA
    Cheng CY
    Shrubsole M
    Long J
    Pylkäs K
    Jukkola-Vuorinen A
    Kauppila S
    Knight JA
    Glendon G
    Mulligan AM
    Tollenaar RA
    Seynaeve CM
    Kriege M
    Hooning MJ
    van den Ouweland AM
    van Deurzen CH
    Lu W
    Gao YT
    Cai H
    Balasubramanian SP
    Cross SS
    Reed MW
    Signorello L
    Cai Q
    Shah M
    Miao H
    Chan CW
    Chia KS
    Jakubowska A
    Jaworska K
    Durda K
    Hsiung CN
    Wu PE
    Yu JC
    Ashworth A
    Jones M
    Tessier DC
    González-Neira A
    Pita G
    Alonso MR
    Vincent D
    Bacot F
    Ambrosone CB
    Bandera EV
    John EM
    Chen GK
    Hu JJ
    Rodriguez-Gil JL
    Bernstein L
    Press MF
    Ziegler RG
    Millikan RM
    Deming-Halverson SL
    Nyante S
    Ingles SA
    Waisfisz Q
    Tsimiklis H
    Makalic E
    Schmidt D
    Bui M
    Gibson L
    Müller-Myhsok B
    Schmutzler RK
    Hein R
    Dahmen N
    Beckmann L
    Aaltonen K
    Czene K
    Irwanto A
    Liu J
    Turnbull C
    Rahman N
    Meijers-Heijboer H
    Uitterlinden AG
    Rivadeneira F
    Olswold C
    Slager S
    Pilarski R
    Ademuyiwa F
    Konstantopoulou I
    Martin NG
    Montgomery GW
    Slamon DJ
    Rauh C
    Lux MP
    Jud SM
    Bruning T
    Weaver J
    Sharma P
    Pathak H
    Tapper W
    Gerty S
    Durcan L
    Trichopoulos D
    Tumino R
    Peeters PH
    Kaaks R
    Campa D
    Canzian F
    Weiderpass E
    Johansson M
    Khaw KT
    Travis R
    Clavel-Chapelon F
    Kolonel LN
    Chen C
    Beck A
    Hankinson SE
    Berg CD
    Hoover RN
    Lissowska J
    Figueroa JD
    Chasman DI
    Gaudet MM
    Diver WR
    Willett WC
    Hunter DJ
    Simard J
    Benitez J
    Dunning AM
    Sherman ME
    Chenevix-Trench G
    Chanock SJ
    Hall P
    Pharoah PD
    Vachon C
    Easton DF
    Haiman CA
    Kraft P
    Pokaż więcej
    Corporate Authors:
    Gene ENvironmental Interaction and breast CAncer (GENICA) Network
    kConFab Investigators
    Familial Breast Cancer Study (FBCS)
    Australian Breast Cancer Tissue Bank (ABCTB) Investigators
    Źródło:
    Nature genetics [Nat Genet] 2013 Apr; Vol. 45 (4), pp. 392-8, 398e1-2.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Genetic Predisposition to Disease*
    Breast Neoplasms/*etiology
    Genetic Loci/*genetics
    Polymorphism, Single Nucleotide/*genetics
    Receptors, Estrogen/*metabolism
    Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Case-Control Studies ; Cooperative Behavior ; Female ; Genome-Wide Association Study ; Genotype ; Humans ; Meta-Analysis as Topic ; Oligonucleotide Array Sequence Analysis ; Receptors, Estrogen/genetics ; Risk Factors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.
    Autorzy:
    Schrauder MG; Department of Obstetrics and Gynaecology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany. Michael.Schrauder@uk-erlangen.de
    Strick R
    Schulz-Wendtland R
    Strissel PL
    Kahmann L
    Loehberg CR
    Lux MP
    Jud SM
    Hartmann A
    Hein A
    Bayer CM
    Bani MR
    Richter S
    Adamietz BR
    Wenkel E
    Rauh C
    Beckmann MW
    Fasching PA
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2012; Vol. 7 (1), pp. e29770. Date of Electronic Publication: 2012 Jan 05.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Early Detection of Cancer*
    Biomarkers, Tumor/*blood
    Breast Neoplasms/*blood
    Breast Neoplasms/*diagnosis
    MicroRNAs/*blood
    Adult ; Aged ; Aged, 80 and over ; Area Under Curve ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Down-Regulation/genetics ; Female ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Humans ; Middle Aged ; Neoplasm Staging ; Oligonucleotide Array Sequence Analysis ; Real-Time Polymerase Chain Reaction ; Reproducibility of Results ; Support Vector Machine ; Up-Regulation/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-9 z 9

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies